Synovir thalidomide: Began a pilot study in 46 patients, to evaluate quality of life, pain, and joint swelling, and serological indicators of the disease

Celgene Corp. (CELG), Warren, N.J. Product: Synovir thalidomide, inhibitor of TNF alpha Indication: Rheumatoid arthritis Status: Began a pilot study in 46 patients, to evaluate quality of life, pain...